Contents 2 min read

Claim and source comparison

Phosphatidylserine: a soy-extract memory trial, an exercise-hormone trial and Health Canada's soy-product safety assessment.

· Bounded source comparison; not a complete clinical review or independent medical endorsement.

Human randomized controlled trial

Kato-Kataoka et al. (2010) assigned 78 people with memory complaints to soy-derived PS at 100 or 300 mg/day or placebo for 6 months. Test scores increased similarly in all groups, including placebo.

Within-group improvement in the low-baseline subgroup is not overall superiority to placebo. Results do not transfer to every product; some authors had institutional ties to Yakult.

Source 2 · Abstract read

Human randomized controlled trial

Starks et al. (2008) compared 600 mg/day PS with placebo for 10 days in a crossover trial in 10 men. Peak cortisol and cortisol area under the curve during moderate exercise were lower; growth hormone did not change.

This small, short hormone trial did not demonstrate memory enhancement, anxiety treatment or long-term stress control. The studied amount is not a personal daily-dose recommendation.

Source 3 · Abstract read

Official safety summary

Health Canada's assessment covers only adding soy-derived PS to foods under specified conditions. The 300 mg/day value is not a safe upper limit for every PS product or a personal-dose recommendation.

This assessment does not establish memory efficacy or safety of all formulations. People with soy allergy should check ingredient labels; choosing another plant source does not automatically eliminate allergy risk.

Source 5 · Official summary read

Our evidence and source methodology

Phosphatidylserine: conceptual editorial illustration
Conceptual editorial artwork; not a research finding or evidence of clinical benefit in humans.

What is Phosphatidylserine?

Crook et al. (1991) studied bovine-brain PS at 300 mg/day for 12 weeks in 149 people with age-associated memory complaints. The result cannot be directly generalized to all soy or sunflower products or healthy young people.

Clinical Evidence

Kato-Kataoka et al. (2010) assigned 78 people with memory complaints to soy-derived PS at 100 or 300 mg/day or placebo for 6 months. Test scores increased similarly in all groups, including placebo.

Within-group improvement in the low-baseline subgroup is not overall superiority to placebo. Results do not transfer to every product; some authors had institutional ties to Yakult.

Starks et al. (2008) compared 600 mg/day PS with placebo for 10 days in a crossover trial in 10 men. Peak cortisol and cortisol area under the curve during moderate exercise were lower; growth hormone did not change.

This small, short hormone trial did not demonstrate memory enhancement, anxiety treatment or long-term stress control. The studied amount is not a personal daily-dose recommendation.

Dose information and research limits

Dose information and research limits

This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.

Safety and Side Effects

Health Canada's assessment covers only adding soy-derived PS to foods under specified conditions. The 300 mg/day value is not a safe upper limit for every PS product or a personal-dose recommendation.

This assessment does not establish memory efficacy or safety of all formulations. People with soy allergy should check ingredient labels; choosing another plant source does not automatically eliminate allergy risk.

Related research and reading

These links show explicit editorial topic connections; they do not confirm a mechanism, efficacy or the safety of combined use. News dates refer to the source or event.

Research and safety news

Sources

  1. Crook TH, et al. (1991). Effects of phosphatidylserine in age-associated memory impairment. Neurology, 41(5), 644–649. PubMed · PMID 2027477
  2. Kato-Kataoka A, et al. (2010). Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints. Journal of Clinical Biochemistry and Nutrition, 47(3), 246–255. PubMed · PMID 21103034
  3. Starks MA, et al. (2008). The effects of phosphatidylserine on endocrine response to moderate intensity exercise. Journal of the International Society of Sports Nutrition, 5, 11. PubMed · PMID 18662395
  4. Glade MJ, Smith K. (2015). Phosphatidylserine and the human brain. Nutrition, 31(6), 781–786. PubMed · PMID 25933483
  5. Health Canada. Summary of Health Canada’s safety assessment of phosphatidylserine for use as a supplemental ingredient. https://www.canada.ca/en/health-canada/services/food-nutrition/public-involvement-partnerships/modification-list-permitted-supplemental-ingredients-enable-use-phosphatidylserine-soy/summary.html Health Canada

Link verification checks the identity of the publication; it does not constitute independent expert review of clinical claims. Our evidence and source methodology · Source directory

Frequently Asked Questions